Biolex Therapeutics

Healthcare Biotechnology

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been optimized to enhance their efficacy and potency. The LEX System is a...

Founded in 1997
Employees: 105
Homepage: http://www.biolex.com/
Total money raised: $154M

Headquarters

27312 158 Credle Street

Pittsboro
USA NC

Phone: 919.542.9901

Updated on Oct 29, 2010
Biolex Therapeutics at CrunchBase

Tags: biotech clinical clinical-stage hepatitis lemna locteron stage therapeutic

Jan Turek President and CEO
Kevin Bitterman Director
Kyle Chenet Director
Past

October, 2010

Biolex Therapeutics raised $20M in a Series D round

Biolex Gets $20M From Insiders, Sees Strong Data From Hepatitis C Drug

fis.dowjones.com

October, 2008

Biolex Therapeutics raised $60M in a Series D round from Dow Venture Capital, Johnson & Johnson Development Corporation, Clarus Ventures, Quaker BioVentures, Bioventures Investors, J.P. Morgan Securities Inc., InterSouth Partners, OrbiMed Advisors, L.L.C., Dogwood Equity, Investor Growth Capital, and Mitsui Ventures

Biolex Therapeutics Completes $60 Million Series D Financing to Accelerate Development of LocteronÂ® in Hepatitis C

mitsuiventures.com

May, 2007

Biolex Therapeutics raised $30M in a Series C round from Investor Growth Capital, JP Morgan, Easton Capital, Quaker BioVentures, Polaris Partners, InterSouth Partners, Mitsui Ventures, Johnson & Johnson Development, and Dow Venture Capital

BIOLEX THERAPEUTICS RAISES $30 MILLION TO ADVANCE ITS HEPATITIS C DRUG CANDIDATE AND OTHER PIPELINE PROGRAMS

September, 2005

Biolex Therapeutics raised $36M in a Series B round from Polaris Partners, InterSouth Partners, Quaker BioVentures, Johnson & Johnson Development Corporation, Mitsui Ventures, and Kitty Hawk Capital

BIOLEX THERAPEUTICS RAISES $36 MILLION IN VENTURE FINANCING

January, 2005

Biolex Therapeutics raised $8M in unattributed round from Johnson & Johnson Development Corporation

1997

Biolex Therapeutics was founded in 1997